Dadachanji Group Unveils KAISHA Pharma with €45 Million Investment
- Nishadil
- September 04, 2026
- 0 Comments
- 2 minutes read
- 2 Views
- Save
- Follow Topic
KAISHA Pharma launched as a global pharma‑packaging player
The Dadachanji Group has poured €45 million into a new venture, KAISHA Pharma, offering glass packaging solutions for pharma and biotech worldwide.
The Dadachanji Group, a name you’ll recognise from three‑plus decades in pharma glass packaging, just announced a fresh chapter. With a fresh infusion of €45 million, the group has set up KAISHA Pharma – a company that aims to serve pharmaceutical and biotechnology firms both in India and abroad.
What does KAISHA actually do? In plain language, it will crank out the whole family of tubular glass containers – think ampoules, vials, prefilled syringes and cartridges. On top of that, the firm plans to roll out Ready‑to‑Use (RTU) platforms for those same formats, giving manufacturers a quicker, safer route from the lab bench to the patient’s bedside.
The ambition isn’t just about volume. KAISHA says its packaging is engineered to meet ever‑tightening global standards, helping clients speed up their fill‑finish steps while keeping product integrity intact. There’s also a special focus on high‑value biologics and delicate drug formulations, where even a tiny change in container chemistry can matter.
Speaking about the launch, Managing Director Kairus Dadachanji noted, “Our past experience has been a defining chapter for us. We want a truly global company that blends entrepreneurial agility with technical excellence and a relentless focus on customer success.” Rishad Dadachanji added, “We have earned trust across the industry over the years. KAISHA builds on that foundation while we embrace the fast‑evolving market.”
In terms of physical footprint, the new manufacturing complex will stretch over 300,000 sq ft. Inside, you’ll find fully integrated production lines, state‑of‑the‑art camera inspection systems and labs bristling with advanced analytical tools. It’s a serious investment in both hardware and know‑how.
To keep the conversation global, KAISHA is also opening an International Business Development office in Europe. That hub will act as a liaison for customers, technical partners and market‑development teams across the continent.
All told, the Dadachanji Group is positioning KAISHA Pharma as a next‑generation packaging partner – one that marries decades of industry know‑how with cutting‑edge manufacturing, all while promising long‑term collaborations.
Editorial note: Nishadil may use AI assistance for news drafting and formatting. Readers can report issues from this page, and material corrections are reviewed under our editorial standards.